Login
Toggle navigation
Videos
Categories
Trending
LivePerson CEO Robert Locascio discusses with Jim Cramer how conversational AI is transforming the call center industry.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
John has served as LivePerson's CEO since January 2024.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
BCI Minerals: Developing the Mahdi Salt and Potash Project at One-to-One Mining Investment Conference
00:10:00
Climate Action and Regulatory Developments by Serena A. Rwejuna | Serena Rwejuna - Partner, Washington, DC of White & Case LLP
00:10:00
JenSource Positions Small-Scale Potash Development as Future of Industry at One-to-One Conference in London
00:10:00
Inside the Minds of Wall Street's Titans: Insights and Predictions from Global Alts 2024
00:10:00
Grantor Retained Annuity Trust: A Tax-Efficient Estate Planning Strategy | Chris Kerckoff, President , Plancorp LLC.
00:10:00
Leo Quinn's Balfour Beatty CEO Presentation: December 13, 2017 | Leo Quinn - CEO of Balfour Beatty
00:10:00
Driving Growth and Innovation: Insights from Paolo Martini | Paolo Martini, CEO , Azimut Holding.
00:10:00
Joel Greenblatt, managing principal and co-chief investment officer of Gotham Asset Management, shares insights on Tesla during a "Squawk Box" interview by phone.|Mr. Greenblatt serves as Managing Principal and Co-Chief Investment Officer of Gotham Asset
00:10:00
Behavioral Finance Insights: Strategies for Overcoming Irrational Financial Decisions
00:10:00
Falcon Gold's Strategic Exploration in the Americas: An Interview with CEO Kareim Ryani
00:10:00
Lithium Chile's High Flow Rates and Resource Expansion in the Lithium Triangle
00:00:00
GraysonAshby, M.D.